Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion type Assertion NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_head.
- NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion wasGeneratedBy ECO_0000203 NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_provenance.
- NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion wasDerivedFrom befree-2016 NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_provenance.
- NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion SIO_000772 22167408 NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_provenance.
- NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion evidence source_evidence_literature NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_provenance.
- NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_assertion description "[The epidermal growth factor receptor (EGFR) inhibitors erlotinib and gefitinib have shown efficacy in patients with NSCLC and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946468.RAZlcpSBnFmT1T1c7fHP7BI1-TpXZc4UG59NlXefqzYx8130_provenance.